About the Journal
The AMAA International Pharma Journal (AIPJ) is a premier peer-reviewed, refereed, indexed quarterly journal under the banner of AMAA Research Publication, headquartered in Minsk, Belarus. Dedicated to the advancement of pharmaceutical sciences, AIPJ is designed to provide a dynamic platform for researchers, scholars, and industry professionals to share innovative insights, cutting-edge research, and developments in the pharmaceutical field.
At the core of our mission is the belief that the pharmaceutical sciences are critical to improving global health outcomes. AIPJ is committed to promoting rigorous academic research, fostering cross-disciplinary collaboration, and ensuring that groundbreaking work in drug development, biotechnology, pharmacology, and other related fields reaches a global audience.
Our Focus Areas Include, not limited to:
- Pharmaceutical Research & Drug Development
- Pharmacology & Toxicology
- Clinical Pharmacy
- Biotechnology in Pharmaceuticals
- Pharmaceutics & Pharmaceutical Chemistry
- Pharmacokinetics & Pharmacodynamics
- Regulatory Affairs & Quality Control
- Herbal & Traditional Medicines
- Pharmacoeconomics & Pharmaceutical Policy
What Sets Us Apart:
-
Rigorous Peer Review: AIPJ maintains high editorial standards, ensuring that every article undergoes a thorough peer-review process by experts in the field, guaranteeing the reliability and scientific integrity of published content.
-
Global Reach: Our journal is accessible to a broad international audience, bridging gaps between academia and the pharmaceutical industry, and promoting global collaboration on critical health and medicine topics.
-
Interdisciplinary Approach: We encourage submissions from related disciplines, acknowledging that innovation in pharmaceutical sciences often occurs at the intersection of fields like biotechnology, chemistry, and medicine.
-
Open Access: AIPJ is committed to the open access model, ensuring that all research published is freely available to readers worldwide, fostering the free exchange of ideas and knowledge.
Our Vision for the Future: As the flagship journal of AMAA Research Publication, AIPJ envisions becoming a leader in pharmaceutical publishing, known for contributing significantly to advancements in drug discovery and healthcare. With our plans to expand into other scientific disciplines, AIPJ represents the first step in building a comprehensive academic publishing platform that caters to researchers and practitioners across a wide range of fields.
Here are some basic details of IJTD :
- AIPJ : AMAA International Pharma Journal
- ISSN: XXXX-XXXX
- Chief Editor: Dr. Alexander Petrov, UK
- Publisher: AMAA Research Publication, Belarus
- Starting Year: 2023
- Frequency: Quarterly [4 issues per year]
- Languages: Multiple Languages
- Accessibility: Open Access
- Crossref DOI Prefix: 10.XXXXXX
- Peer Review Process: Double Blind Peer Review Process
- Subject: Pharmacy
- Plagiarism Checker: Turnitin
- Publication Format: Online
- Contact No.: +375-315615748
- Email: amaaresearchpublication@gmail.
com - Website: https://pharmajournal.org
- Address : Minsk-220005, Belarus
Key Features of AIPJ
- Journal listed in Google Scholar
- Indexed with Crossref DOI
- Journal Publishes online on continuous basis
- Online article submission
- Standard double blind peer review process
Join us in shaping the future of pharmaceutical sciences by contributing to and reading the AMAA International Pharma Journal—where innovation meets impact.